UB Paderborn / Katalog / Suche / in CDI

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells

The Journal of immunology (1950), 2017-01, Vol.198 (2), p.729-740

2017

Link zum Volltext

Verfügbarkeit prüfen

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Oncoimmunology, 2023-12, Vol.12 (1), p.2219591-2219591

2023

Link zum Volltext

Verfügbarkeit prüfen

Gliadin Fragments Induce Phenotypic and Functional Maturation of Human Dendritic Cells

Journal of Immunology, 2005-11, Vol.175 (10), p.7038-7045

2005

Link zum Volltext

Verfügbarkeit prüfen

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix

Translational oncology, 2024-03, Vol.41, p.101884-101884, Article 101884

2024

Link zum Volltext

Verfügbarkeit prüfen

Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases

Annals of the New York Academy of Sciences, 2005-06, Vol.1051 (1), p.787-798

2005

Link zum Volltext

Verfügbarkeit prüfen

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

PloS one, 2020-11, Vol.15 (11), p.e0242092-e0242092

2020

Link zum Volltext

Verfügbarkeit prüfen

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Frontiers in immunology, 2019-02, Vol.10, p.79-79

2019

Link zum Volltext

Verfügbarkeit prüfen

Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation

PloS one, 2013-04, Vol.8 (4), p.e62426

2013

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy in Combination With Cytokine Treatment

Frontiers in oncology, 2019-05, Vol.9, p.367-367

2019

Link zum Volltext

Verfügbarkeit prüfen

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Frontiers in immunology, 2019-10, Vol.10, p.2393-2393

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Frontiers in immunology, 2019-05, Vol.10, p.967-967

2019

Link zum Volltext

Verfügbarkeit prüfen

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice

Frontiers in immunology, 2018-02, Vol.9, p.290-290

2018

Link zum Volltext

Verfügbarkeit prüfen

Gliadin fragments promote migration of dendritic cells

Journal of cellular and molecular medicine, 2011-04, Vol.15 (4), p.938-948

2011

Link zum Volltext

Verfügbarkeit prüfen

High hydrostatic pressure in cancer immunotherapy and biomedicine

Biotechnology advances, 2018-05, Vol.36 (3), p.577-582

2018

Link zum Volltext

Verfügbarkeit prüfen

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

PloS one, 2020-01, Vol.15 (11)

2020

Link zum Volltext

Verfügbarkeit prüfen

Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy

PloS one, 2012-05, Vol.7 (5), p.e37156-e37156

2012

Link zum Volltext

Verfügbarkeit prüfen

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment

Oncotarget, 2015-06, Vol.6 (16), p.14123-14138

2015

Link zum Volltext

Verfügbarkeit prüfen

713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A808-A808

2023

Link zum Volltext

Verfügbarkeit prüfen

815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A914-A914

2023

Link zum Volltext

Verfügbarkeit prüfen

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients

Data in brief, 2019-08, Vol.25, p.104321-104321, Article 104321

2019

Link zum Volltext

Verfügbarkeit prüfen

Gliadin peptides activate blood monocytes from patients with celiac disease

Journal of Clinical Immunology, 2007-03, Vol.27 (2), p.201-209

2007

Link zum Volltext

Verfügbarkeit prüfen

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1196-A1196

2023

Link zum Volltext

Verfügbarkeit prüfen

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients

Journal of autoimmunity, 2019-12, Vol.105, p.102294-102294, Article 102294

2019

Link zum Volltext

Verfügbarkeit prüfen

Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor βγ superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2502-2502

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents

Trends in cancer, 2022-05, Vol.8 (5), p.426-444

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Gliadin Fragments Induce Phenotypic and Functional Maturation of Human Dendritic Cells

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix

Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation

Radiotherapy in Combination With Cytokine Treatment

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice

Gliadin fragments promote migration of dendritic cells

High hydrostatic pressure in cancer immunotherapy and biomedicine

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment

713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers

815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients

Gliadin peptides activate blood monocytes from patients with celiac disease

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients

Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor βγ superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents

Suchergebnisse filtern